Intech Biopharm Corporation (TPEX:6461)
25.85
+0.10 (0.39%)
Feb 17, 2025, 9:00 AM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 3.64 billion as of February 21, 2025. Its market cap has decreased by -6.02% in one year.
Market Cap
3.64B
Enterprise Value
4.74B
Revenue
34.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.85
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 3.64B, a decrease of -9.06%. That is a compound annual growth rate of -0.89%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
PharmaEssentia | 209.72B |
Caliway Biopharmaceuticals | 142.08B |
Bora Pharmaceuticals Co., LTD. | 89.70B |
Lotus Pharmaceutical | 71.92B |
Lumosa Therapeutics | 39.78B |
Oneness Biotech | 38.63B |
Polaris Group | 36.08B |
Pegavision | 30.26B |